Briefings

What is changing in the rules, what it means for your product, your municipality or your project, and who here handles it. In English and Portuguese.

Monitoring reports, cosmetic products

Our monitoring reports record the changes to cosmetics rules in a given period, and we publish one each month. Each one is a dated publication: it reflects the rules on the date it was published and is not updated afterwards. For what applies today, read the latest briefings or ask us.

210 items

Results

Monitoring report

Ban on CMR substances in cosmetic products applicable from 1 December 2023

Ingredients: BENZOPHENONE, TEOPHYLLINE, PENTETIC ACID, PENTASODIUM PENTETATE

Date of publication: 08/06/2023

On 8 June 2023, the European Commission published an amendment of Annex XVII to the Regulation (EC) 1907/2006 (REACH) regarding substances recently classified as Carcinogenic, Mutagenic, or Reprotoxic (CMR). The ban is applicable from 1 december 2023.

Monitoring report

French Court revokes restrictions on the Green Dot symbol

GREEN DOT SYMBOL - FRANCE

Date of publication: 30/06/2023

On June 30, 2023, the French Supreme Administrative Court has declared the decree issued by the French Environment Ministry regarding the Green Dot trademark to be null and void.

Monitoring report

SCCS issues Preliminary Opinion on Benzyl Salicylate

Ingredients: BENZYL SALICYLATE

Date of publication: 13/06/2023

On June 13, 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Benzyl Salicylate as used in cosmetic products.

Monitoring report

SCCS publishes Preliminary Opinion on Water-Soluble Zinc Salts

Ingredients: WATER-SOLUBLE ZINC SALTS

Date of publication: 04/07/2023

On July 4, 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Water-Soluble Zinc Salts as used in cosmetic products.

Monitoring report

SCCS issues Preliminary Opinions on Methylparaben and Butylparaben

Ingredients: METHYLPARABEN, BUTYLPARABEN

Date of publication: 08/06/2023

On June 8, 2023, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinions on the safety of Methylparaben and Butylparaben when used as preservatives in cosmetic products.

Monitoring report

European Commission mandates SCCS to assess the inhalation toxicity of Acetylated Vetiver Oil (AVO) in sprayable cosmetic products

Ingredients: ACETYLATED VETIVER OIL

Date of publication: 09/06/2023

On June 9, 2023, the European Commission requested the the Scientific Committee on Consumer Safety (SCCS) to carry out an evaluation on the inhalation toxicity of a fragrance ingredient, Acetylated Vetiver Oil (AVO), as used in sprayable cosmetic products.

Cosmetic Products

Monitoring report

European Commission requests SCCS Opinion on the safety of Cyclamen Aldehyde

Ingredient: CYCLAMEN ALDEHYDE

Date of publication: 8 June 2026

The Scientific Committee on Consumer Safety (SCCS) has accepted a mandate to assess the safety of Cyclamen Aldehyde, following potential classification as a reproductive toxicant under the CLP Regulation.

Monitoring report

European Cosmetics Regulation – Updates on Cosmetic Ingredients  

Topic: NEW RESTRICTIONS ON COSMETIC INGREDIENTS

Date of publication: 13 January 2026

The European Commission published Commission Regulation (EU) 2026/78, which brings new restrictions on several cosmetic ingredients that were classified as Carcinogenic, Mutagenic or Toxic for Reproduction (CMR).

Monitoring report

United Kingdom publishes Technical Report on the Classification and Labelling of Talc 

Ingredient: TALC

Date of publication: January 2026

The United Kingdom (UK) Health and Safety Executive (HSE) has published a technical report concluding that Talc does not warrant carcinogenicity classification, diverging from ECHA's Risk Assessment Committee (RAC) opinion supporting Category 1B classification.

Medical Devices

EU

How to demonstrate equivalence under the MDR

Clinical data from an equivalent device can support your clinical evaluation, but the MDR sets a higher bar than the Directives did. The three characteristics, data access, and documentation.

Follow an area

One email when an area publishes, in the language you choose. Nothing else.